IMS 0.00% 69.0¢ impelus limited

Financial analysis of DCB impact on 2018 EBITDA, page-106

  1. 808 Posts.
    lightbulb Created with Sketch. 79
    I did dd on this little puppy years years ago when it was around the same share price. I did some consulting work with one of the regulatory bodies for a few months and got a bit of an insight into their previous (but similar) DCB model. And then I met the mighty Thorpe and Wiles.

    I decided not to proceed even though they reached lofty heights soon after. And then crashed back down.

    Call it curiosity. I invested a lot of time researching and feel a need to ensure that I was on the right track. Old people do that sometimes.

    If someone takes a moment or two to think about some of my comments, especially on some of the start-up train wrecks out there at the moment, and applies some of their own due diligence as a result, then I guess my job is done.

    Otherwise, please feel free to ignore me. I've only been doing this for about 40 years.

    BTW, I sometimes comment on the stocks I currently hold but I understand their business models and trust their management. When and if I ever get nervous, I sell. I never make excuses or pray to the gods.
 
watchlist Created with Sketch. Add IMS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.